All
Applying Eyebrow, Eye Makeup To Negate Appearance-Related Effects From Cancer
October 25th 2023In this on-demand webinar series, CURE partnered with Look Good Feel Better to discuss eyebrow shaping techniques and applying eye shadow and mascara to address appearance-related effect from cancer treatment.
Approval of Braftovi With Mektovi Adds to Targeted Options for Metastatic NSCLC
October 24th 2023Dr. Gene G. Finley of Drexel University of College of Medicine and AHN Cancer Institute, Allegheny Clinic Medical Oncology, explains why the approval of Braftovi and Mektovi “It's an important improvement in our armamentarium.”
Presurgical Keytruda Plus Chemotherapy Improves Response for Some With Breast Cancer
October 23rd 2023Neoadjuvant Keytruda plus chemotherapy followed by adjuvant Keytruda plus endocrine therapy generated a statistically significant increase in pathologic complete response compared to pre-surgical placebo and chemotherapy followed by adjuvant Keytruda and endocrine therapy for patients with high-risk, early-stage, estrogen receptor–positive, HER2-negative breast cancer.
Tivdak Confers 30% Reduction in Mortality Risk in Cervical Cancer
October 22nd 2023A 30% reduction in the risk of death versus. investigator’s choice of chemotherapy as second or third line therapy was concluded when Tivdak was combined for the treatment of recurrent or metastatic cervical cancer with disease progression on doublet chemotherapy.